NEW YORK, Oct. 28, 2015 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM) commends Anavex Life Sciences Corp., a clinical-stage biopharmaceutical company developing drug candidates to treat Alzheimer's disease, other central nervous system (CNS) diseases, pain and various types of cancer, on its graduation today to the NASDAQ Capital Market. Anavex previously traded on the OTCQX® Best Market, operated by OTC Markets Group.
Since Anavex was approved to trade on OTCQX on December 12, 2014, the company's share price has increased over 1,000% and its 30-day average daily dollar volume has increased over 160-fold, reflecting increased investor interest in its securities.
"The OTCQX Best Market provides a tremendous platform for developing companies like Anavex that seek to grow their businesses, attract new investors and qualify for a U.S. exchange listing," said Jason Paltrowitz, Executive Vice President - Corporate Services of OTC Markets Group. "We are proud to have contributed to Anavex's achievement of this important milestone and wish the company and its management team continued success in the public markets."
"Trading on OTCQX made it possible for Anavex to increase both its visibility and liquidity to contribute to long-term shareholder value," said Christopher U. Missling, Ph.D., President and CEO of Anavex.
Anavex is the 53rd company to graduate to a U.S. stock exchange this year. Other 2015 graduates have included: AmpliPhi Biosciences Corp., CRH Medical Corp. and Staffing 360 Solutions Inc.
OTC Markets Group is a global leader in exchange graduates, advancing more than 400 companies to the New York Stock Exchange, NASDAQ and NYSE MKT since 2009.
About OTC Markets Group Inc.
OTC Markets Group Inc. (OTCQX: OTCM) operates Open, Transparent and Connected financial markets for 10,000 U.S. and global securities. Through our OTC Link® ATS, we directly link a diverse network of broker-dealers that provide liquidity and execution services for a wide spectrum of securities. We organize these securities into markets to inform investors of opportunities and risks: the OTCQX® Best Market; the OTCQB® Venture Market; and the OTC Pink® Open Market. Our data-driven platform enables investors to easily trade through the broker of their choice at the best possible price and empowers a broad range of companies to improve the quality and availability of information for their investors. To learn more about how we create better informed and more efficient financial markets, visit www.otcmarkets.com.
OTC Link ATS is operated by OTC Link LLC, member FINRA/SIPC and SEC regulated ATS.
Saskia Sidenfaden, OTC Markets Group Inc., +1 (212) 896-4428, [email protected]
SOURCE OTC Markets Group Inc.